Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes
- PMID: 12086956
- DOI: 10.2337/diabetes.51.7.2241
Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes
Abstract
To reconstruct the events that may contribute to the accelerated death of retinal vascular cells in diabetes, we investigated in situ and in vitro the activation of nuclear factor-kappaB (NF-kappaB), which is triggered by cellular stress and controls several programs of gene expression. The retinal capillaries of diabetic eye donors showed an increased number of pericyte nuclei positive for NF-kappaB, when compared with nondiabetic donors, whereas endothelial cells were negative. Microvascular cell apoptosis and acellular capillaries were increased only in the diabetic donors with numerous NF-kappaB-positive pericytes. Likewise, high glucose in vitro activated NF-kappaB in retinal pericytes but not in endothelial cells, and increased apoptosis only in pericytes. Studies with NF-kappaB inhibitors suggested that in pericytes, basal NF-kappaB has prosurvival functions, whereas NF-kappaB activation induced by high glucose is proapoptotic. Pericytes exposed to high glucose showed increased expression of Bax and of tumor necrosis factor-alpha, which were prevented by the NF-kappaB inhibitors and mimicked by transfection with the p65 subunit of NF-kappaB, and failed to increase the levels of the NF-kappaB-dependent inhibitors of apoptosis. Colocalization of activated NF-kappaB and Bax overexpression was observed in the retinal pericytes of diabetic donors. A proapoptotic program triggered by NF-kappaB selectively in retinal pericytes in response to hyperglycemia is a possible mechanism for the early demise of pericytes in diabetic retinopathy.
Similar articles
-
Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.Am J Pathol. 2000 Mar;156(3):1025-32. doi: 10.1016/S0002-9440(10)64970-X. Am J Pathol. 2000. PMID: 10702418 Free PMC article.
-
Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.Diabetes. 2004 Nov;53(11):2960-7. doi: 10.2337/diabetes.53.11.2960. Diabetes. 2004. PMID: 15504977
-
Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction.Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1535-43. Invest Ophthalmol Vis Sci. 1998. PMID: 9699542
-
Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.Diabetes Obes Metab. 2008 Jan;10(1):53-63. doi: 10.1111/j.1463-1326.2007.00795.x. Epub 2007 Oct 15. Diabetes Obes Metab. 2008. PMID: 17941874 Review.
-
Pericytes and the pathogenesis of diabetic retinopathy.Horm Metab Res. 2005 Apr;37 Suppl 1:39-43. doi: 10.1055/s-2005-861361. Horm Metab Res. 2005. PMID: 15918109 Review.
Cited by
-
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?Biol Res. 2014 Nov 18;47:58. doi: 10.1186/0717-6287-47-58. Biol Res. 2014. PMID: 25723058 Free PMC article. Review.
-
Noninvasive temporal detection of early retinal vascular changes during diabetes.Sci Rep. 2020 Oct 15;10(1):17370. doi: 10.1038/s41598-020-73486-2. Sci Rep. 2020. PMID: 33060607 Free PMC article.
-
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12. FASEB J. 2012. PMID: 22499584 Free PMC article.
-
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy.Int J Mol Sci. 2021 Apr 13;22(8):4020. doi: 10.3390/ijms22084020. Int J Mol Sci. 2021. PMID: 33924714 Free PMC article. Review.
-
Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.Diabetes Care. 2010 Jul;33(7):1523-8. doi: 10.2337/dc09-2372. Epub 2010 Apr 22. Diabetes Care. 2010. PMID: 20413522 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials